Nanexa strengthen the team with professor Axel Glasmacher as medical advisor
Newsletter
Uppsala 24thSeptember 2018
Nanexa strengthen the team with professor Axel Glasmacher as medical advisor
Nanexa has contracated Professor Axel Glasmacher as medical advisor to the drug product project within the cancer indications MDS (Severe myelodysplastic syndrome) and AML (Acute myeloid leukemia).
New positive results from animal study
Pressrelease
Uppsala 31st May 2018
New positive results from animal study
Nanexa has obtained results from a week-long animal study conducted during the month of May.
